In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs
about
Telomerase as a Cancer Target. Development of New MoleculesAging and HIV/AIDS: pathogenetic role of therapeutic side effectsAging of the human innate immune system in HIV infection.No difference in the rate of change in telomere length or telomerase activity in HIV-infected patients after three years of darunavir/ritonavir with and without nucleoside analogues in the MONET trialChoice of antiretroviral therapy differentially impacts survival of HIV-infected CD4 T cellsAntiretroviral therapy-induced toxicity is associated with increased mRNA expression of telomerase.Premature aging and immune senescence in HIV-infected children.Optimization of a Relative Telomere Length Assay by Monochromatic Multiplex Real-Time Quantitative PCR on the LightCycler 480: Sources of Variability and Quality Control Considerations.Oxidative guanine base damage regulates human telomerase activity.Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.Beyond the polymerase-γ theory: Production of ROS as a mode of NRTI-induced mitochondrial toxicity.Increased CD127+ and decreased CD57+ T cell expression levels in HIV-infected patients on NRTI-sparing regimens.Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length.Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion.
P2860
Q28079188-B46D8ABB-9631-4FA1-BCFB-91BEE64D29BDQ34089694-AE935126-5637-4064-BD4A-A80A26955443Q34094201-DC00B77D-3590-46E4-9DA6-FA0DB84CDE20Q34450075-5427CB07-BAC8-4EFE-99BD-6F386EC38A32Q35111879-B20993D2-62A3-4C24-84BE-44D42AE23805Q36021308-9EE1AF51-BBCA-4959-A39A-D5F4FCDC2803Q36903898-E3B795AE-C50A-4A38-9C2B-069DDCC9BF20Q38381687-466D0227-E701-4B27-9C9E-76C65016358CQ38732527-B350FB4F-B98B-4B00-8C14-BA43D8C92C21Q40253152-0CFC8A63-7F87-42B5-9FB2-BF820067E233Q44797235-23EEC80B-8860-4753-AA69-A27B715D17F5Q47562735-A611D7CE-46C2-4105-8E24-6F9DD77A729FQ54204063-32982868-A9EF-435E-862F-1D495CF68A00Q54366710-D3C329B1-9E3D-4414-A213-B9A93C16D5F0
P2860
In vitro and ex vivo inhibition of human telomerase by anti-HIV nucleoside reverse transcriptase inhibitors (NRTIs) but not by non-NRTIs
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@ast
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@en
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@nl
type
label
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@ast
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@en
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@nl
prefLabel
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@ast
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@en
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@nl
P2093
P2860
P1433
P1476
In vitro and ex vivo inhibitio ...... s (NRTIs) but not by non-NRTIs
@en
P2093
Hélène C F Côté
Kyle R Hukezalie
Naresh R Thumati
P2860
P304
P356
10.1371/JOURNAL.PONE.0047505
P407
P50
P577
2012-01-01T00:00:00Z